Showing results (91-100 of 119) with videos related to
Sort By:
Pageof 12
Cell Calcium|March 23, 2010
Egr-1-A Ca(2+)-regulated transcription factorGerald Thiel, Sabine I Mayer, Isabelle Müller, et al.The Biochemical Journal|March 28, 2006
Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbetaYue Zhou, Fang Zhang, Parveen Abidi, et al.Journal of Cell Science|August 27, 2009
Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factorsSabine I Mayer, Oliver G Rössler, Takeshi Endo, et al.Gene|June 26, 2008
Characterization of the bovine angiotensin converting enzyme promoter: essential roles of Egr-1, ATF-2 and Ets-1 in the regulation by phorbol esterOgnoon Mungunsukh, Ana P Marquez, Young H Lee, et al.Cellular and Molecular Life Sciences : CMLS|March 27, 2010
CK2 phosphorylation of Pdx-1 regulates its transcription factor activityRui Meng, Faizeh Al-Quobaili, Isabelle Müller, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 2011
Egr-1 transactivates Bim gene expression to promote neuronal apoptosisBo Xie, Chong Wang, Zhihao Zheng, et al.Biochemical Pharmacology|February 17, 2018
Stimulation of TRPV1 channels activates the AP-1 transcription factorTobias M Backes, Oliver G Rössler, Xin Hui, et al.The Journal of Biological Chemistry|June 6, 2003
The protein phosphatase-1 (PP1) regulator, nuclear inhibitor of PP1 (NIPP1), interacts with the polycomb group protein, embryonic ectoderm development (EED), and functions as a transcriptional repressorQiming Jin, Aleyde van Eynde, Monique Beullens, et al.Journal of Neuroscience Research|July 18, 2003
Transforming growth factor-beta and tumor necrosis factor-alpha cooperate to induce apoptosis in the oligodendroglial cell line OLI-neuNorbert Schuster, Herdis Bender, Oliver G Rössler, et al.Biochemical Pharmacology|July 31, 2002
Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940Nina Erlandsson, Bernd Baumann, Oliver G Rössler, et al.Pageof 12